Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
advances decrease » advanced defense (Expand Search)
advanced disease » advanced stage (Expand Search), advanced breast (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
advances decrease » advanced defense (Expand Search)
advanced disease » advanced stage (Expand Search), advanced breast (Expand Search)
-
1401
Image 4_Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinem...
Published 2025“…Multifactorial analysis showed that MELD score >18 and increased total bilirubin (TBIL) levels within one week were significant risk factors for OS. Patients with a decrease in TBIL levels within one week had significantly prolonged median OS (not reached vs 3.3months, P =0.013) and median PFS (7.03 months vs 2.77 months, P =0.010).…”
-
1402
Image 2_Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinem...
Published 2025“…Multifactorial analysis showed that MELD score >18 and increased total bilirubin (TBIL) levels within one week were significant risk factors for OS. Patients with a decrease in TBIL levels within one week had significantly prolonged median OS (not reached vs 3.3months, P =0.013) and median PFS (7.03 months vs 2.77 months, P =0.010).…”
-
1403
Table 1_Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinem...
Published 2025“…Multifactorial analysis showed that MELD score >18 and increased total bilirubin (TBIL) levels within one week were significant risk factors for OS. Patients with a decrease in TBIL levels within one week had significantly prolonged median OS (not reached vs 3.3months, P =0.013) and median PFS (7.03 months vs 2.77 months, P =0.010).…”
-
1404
Image 3_Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinem...
Published 2025“…Multifactorial analysis showed that MELD score >18 and increased total bilirubin (TBIL) levels within one week were significant risk factors for OS. Patients with a decrease in TBIL levels within one week had significantly prolonged median OS (not reached vs 3.3months, P =0.013) and median PFS (7.03 months vs 2.77 months, P =0.010).…”
-
1405
Image 1_Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinem...
Published 2025“…Multifactorial analysis showed that MELD score >18 and increased total bilirubin (TBIL) levels within one week were significant risk factors for OS. Patients with a decrease in TBIL levels within one week had significantly prolonged median OS (not reached vs 3.3months, P =0.013) and median PFS (7.03 months vs 2.77 months, P =0.010).…”
-
1406
-
1407
-
1408
-
1409
Improvement effect of lactoferrin and Coenzyme Q10 on body composition of mice with sarcopenia.
Published 2025Subjects: -
1410
-
1411
KEGG pathway enrichment analysis of lactoferrin and Coenzyme Q10 in sarcopenia.
Published 2025Subjects: -
1412
The relationship between longer TV watching time and risk of cognitive impairment.
Published 2025Subjects: -
1413
-
1414
-
1415
-
1416
Socio-demographic characteristics of hypertensive patients’ caregivers (n = 422).
Published 2025Subjects: -
1417
-
1418
-
1419
-
1420